NCT07136896

Brief Summary

" Nutritional assessment in patients of Mucopolysaccharide "

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
4mo left

Started Aug 2025

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress70%
Aug 2025Aug 2026

First Submitted

Initial submission to the registry

August 9, 2025

Completed
7 days until next milestone

Study Start

First participant enrolled

August 16, 2025

Completed
6 days until next milestone

First Posted

Study publicly available on registry

August 22, 2025

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 30, 2026

Expected
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

August 30, 2026

Last Updated

August 22, 2025

Status Verified

August 1, 2025

Enrollment Period

12 months

First QC Date

August 9, 2025

Last Update Submit

August 15, 2025

Conditions

Keywords

Caloric deficiencyPediatric nutrition

Outcome Measures

Primary Outcomes (3)

  • Prevalence of malnutrition among patients with mucopolysaccharidosis

    The percentage of patients diagnosed with malnutrition, as determined using the World Health Organization (WHO) growth standards. Malnutrition will be defined based on weight-for-age, height-for-age, and weight-for-height Z-scores below -2 standard deviations. Data will be collected at baseline and expressed as a percentage of the study population.

    1 year

  • severity of malnutrition among patients with mucopolysaccharidosisby WHO growth standards Z-scores (weight-for-age, height-for-age, weight-for-height)

    Severity of malnutrition will be assessed using the Gomez classification based on weight-for-age percentage of the median for the reference population. Categories include: mild (75-89%), moderate (60-74%), and severe (\<60%). Data will be expressed as the proportion of patients in each severity category at baseline

    At baseline (upon enrollment)

  • Prevalence and severity of malnutrition among patients with mucopolysaccharidosis

    The proportion of patients diagnosed with mucopolysaccharidosis (MPS) who present with any degree of malnutrition, categorized as mild, moderate, or severe according to WHO growth standards. Severity will be determined using anthropometric indices (weight-for-age, height-for-age, BMI-for-age z-scores, and mid-upper arm circumference) and compared across disease subtypes and age groups.

    At baseline (upon enrollment)

Study Arms (1)

Nutritional Assessment in Children with Mucopolysaccharidosis

OTHER

Participants diagnosed with Mucopolysaccharidosis will undergo detailed nutritional assessment, including anthropometric measurements, skinfold thickness evaluation, and bioelectrical impedance analysis. Dietary intake will be recorded, and relevant biochemical parameters will be measured.

Other: Nutritional Assessment Protocol

Interventions

Participants will undergo a comprehensive nutritional assessment, including anthropometric measurements (weight, height, BMI, skinfold thickness), dietary intake evaluation through 24-hour recall, and bioelectrical impedance analysis to assess body composition. Relevant biochemical parameters will also be measured to evaluate nutritional status

Nutritional Assessment in Children with Mucopolysaccharidosis

Eligibility Criteria

Age1 Year - 18 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • Age between 1 and 18 years
  • Stable clinical condition at time of enrollment
  • Informed consent obtained from parent/guardian, and assent from child when applicable -

You may not qualify if:

  • Acute illness or hospitalization within the last 2 weeks prior to assessment
  • Patients who received nutritional supplementation or dietary intervention within 3 months prior to enrollment that could affect baseline nutritional assessment
  • Refusal or inability to comply with study assessments

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

MucopolysaccharidosesMalnutrition

Condition Hierarchy (Ancestors)

Carbohydrate Metabolism, Inborn ErrorsMetabolism, Inborn ErrorsGenetic Diseases, InbornCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesLysosomal Storage DiseasesMucinosesConnective Tissue DiseasesSkin and Connective Tissue DiseasesMetabolic DiseasesNutritional and Metabolic DiseasesNutrition Disorders

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
SINGLE GROUP
Model Details: Participants will be assigned to one of two parallel groups: children with mucopolysaccharidosis (MPS) and age-matched healthy controls. Both groups will undergo the same nutritional assessment protocol for comparison.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator,

Study Record Dates

First Submitted

August 9, 2025

First Posted

August 22, 2025

Study Start

August 16, 2025

Primary Completion (Estimated)

July 30, 2026

Study Completion (Estimated)

August 30, 2026

Last Updated

August 22, 2025

Record last verified: 2025-08